Imagine Pharma
Imagine Pharma is a biotechnology company focused on developing its IMG-1 polypeptide across three platforms: Oral Delivery, Therapeutics, and Regenerative Medicine. The company aims to create first-in-class treatments to improve patient outcomes, including curing diabetes, healing wounds faster, and replacing injections with oral biologics. It has built a state-of-the-art laboratory in Pittsburgh and collaborates with leading research institutions and healthcare providers. The company's mission is to advance innovative therapies for large underserved markets and improve the quality of life for patients with complex conditions.
Industries
Nr. of Employees
small (1-50)
Patents
Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-11612637-B2
View DetailsCompositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-10751384-B2
View DetailsCompositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-10548941-B2
View Details
Compositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-11612637-B2
View DetailsCompositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-10751384-B2
View DetailsCompositions and methods for treating diabetes, hypertension and hypercholesterolemia
US-10548941-B2
View DetailsProducts
Polypeptide-based dietary supplement (professional-grade)
A professional-grade dietary supplement formulated around a novel polypeptide designed to support progenitor cell regeneration and general wellness; developed for distribution to healthcare professionals and planned consumer channels.
Polypeptide-based dietary supplement (professional-grade)
A professional-grade dietary supplement formulated around a novel polypeptide designed to support progenitor cell regeneration and general wellness; developed for distribution to healthcare professionals and planned consumer channels.
Services
Clinical-grade islet isolation and preparation to support total pancreatectomy and autologous islet transplantation, provided at company and partner facilities.
Research-grade human islet isolation and distribution to academic and research institutions, including participation in a national islet distribution program.
Consulting to establish islet laboratories, training programs for human and animal islet isolation and culture, and optimization/troubleshooting of isolation protocols.
Fixation, preservation, and banking of pancreatic tissue and cell samples from human donors for research applications.
Preparation of living pancreatic tissue slices for ex vivo functional studies of endocrine and exocrine interactions.
Joint research collaborations to develop cell therapies and advance preclinical proof-of-concept programs with external biotechnology and academic partners.
Clinical-grade islet isolation and preparation to support total pancreatectomy and autologous islet transplantation, provided at company and partner facilities.
Research-grade human islet isolation and distribution to academic and research institutions, including participation in a national islet distribution program.
Consulting to establish islet laboratories, training programs for human and animal islet isolation and culture, and optimization/troubleshooting of isolation protocols.
Fixation, preservation, and banking of pancreatic tissue and cell samples from human donors for research applications.
Preparation of living pancreatic tissue slices for ex vivo functional studies of endocrine and exocrine interactions.
Joint research collaborations to develop cell therapies and advance preclinical proof-of-concept programs with external biotechnology and academic partners.
Expertise Areas
- Islet isolation and processing
- Cell therapy and regenerative medicine
- Oral biologic formulation and delivery
- Early-stage drug discovery and preclinical development
Key Technologies
- Polypeptide discovery and engineering
- Oral peptide/protein formulation
- Islet isolation and purification technologies
- Activated islet progenitor cell culture and propagation
News & Updates
Fierce Pharma Forward event recording on drug development and delivery insights for 2024.
WVU Medicine awarded a contract to Imagine Pharma to provide human islet isolation services for autologous transplantation.
Completed 40 clinical human islet cell isolation procedures supporting leading healthcare institutions.
Fierce Pharma Forward event recording on drug development and delivery insights for 2024.
WVU Medicine awarded a contract to Imagine Pharma to provide human islet isolation services for autologous transplantation.
Completed 40 clinical human islet cell isolation procedures supporting leading healthcare institutions.